TCTAP 2014

Sanofi-Aventis

Sanofi Korea has established foundation for solidifying its position as a comprehensive healthcare leader that satisfies diversified needs of patients and consumers in Korea through business strategies of comprising broad areas of prevention,treatment, and consumer healthcare.

235 Banpo-daero, Seocho-Gu, Seoul
+82-2-2136-9106
http://www.sanofi.co.kr

Booth No. E028

Exhibition Item
Plavix is the key medical necessity in antiplatelet treatment to prevent atherothrombotic events for patients with ACS, Stroke, PAD and A-fib

Satellite Symposium

The Latest Perspectives on Clinical Benefits and Limitations of Antiplatelet Treatment
Organized by CVRF and Supported by Educational Grant from SANOFI Korea
Wednesday, April 23 12:45 PM - 1:45 PM Room 2-1, Level 2
Moderator(s): Hyeon-Cheol Gwon
Panelist(s): Youngkeun Ahn, Jang-Whan Bae, Kwang Soo Cha, Kook-Jin Chun, Joo-Yong Hahn, Jung-Sun Kim, Sung Uk Kwon, Han Cheol Lee, Sang Gon Lee, Seung-Jin Oh, Yongwhi Park

12:45 PM	Opening Remark Speaker : Hyeon-Cheol Gwon
12:48 PM	Review the Benefits and Limitations of Current Antiplatelet Therapy Lecturer : Seung-Jin Oh
1:03 PM	Debate on Duration of Antiplatelet Therapy After PCI Lecturer : Joo-Yong Hahn
1:18 PM	Advances in Atherothrombosis Management in the Complex Patients Lecturer : Jung-Sun Kim
1:33 PM	Panel Discussion and Closing Speaker : Hyeon-Cheol Gwon